Aviation Materials Co., Ltd. released the Procurement Project of Feasibility Study Report of Beijing Aviation Materials Research Institute Co., Ltd., and China Hangfa Online Mall released the Project of Feasibility Study Report of Beijing Aviation Materials Research Institute Co., Ltd.. The publishing unit is Beijing Institute of Aeronautical Materials Co., Ltd. (Aeronautical Materials Co., Ltd., 688563). Services include: feasibility study report of equity acquisition project; Feasibility study report on technology patent acquisition.Since January 1, 2025, Chongqing maternity allowance has been issued to the insured female employees themselves. Recently, Chongqing Medical and Social Security Bureau issued the Notice on Adjusting the Payment Method for Maternity Insurance Benefits, and adjusted the payment method for maternity insurance benefits. From January 1, 2025, the application and method of maternity insurance benefits for the insured shall be applied by the insured himself or his client and issued to him by the medical insurance agency. In order to optimize the processing flow of maternity allowance, the service of "enjoy the maternity allowance immediately upon application" has been opened, that is, when the designated medical institutions in Chongqing settle the maternity medical expenses (delivery and termination of pregnancy), the medical insurance system automatically obtains the maternity-related information to calculate the maternity allowance, and the maternity allowance is paid to the insured after being approved by the medical insurance agency, and the insured or their clients do not need to provide relevant information to the medical insurance agency to declare the offline maternity allowance.
The second "Standards Week" of the National Network Security Standardization Technical Committee was held in Haikou in 2024, and the second "Standards Week" of the National Network Security Standardization Technical Committee (referred to as "Network Security Standardization Committee") was held in Haikou City, Hainan Province from December 8 to 11, 2024. Wang Jingtao, deputy director of the Central Network Information Office, deputy director of the National Network Information Office and chairman of the Network Security Standards Committee, pointed out that standards should help data security governance and supervision, speed up the development of standards such as data classification and classification protection requirements and compliance audit of personal information protection, and ensure the safe and orderly flow of data. It is necessary to lead the safe and orderly development of new technologies and applications such as artificial intelligence with standards and norms, accelerate the development and release of standards such as "Identification Method of Synthetic Content Generated by Artificial Intelligence", strengthen the research on relevant network security standards such as intelligent networked vehicles and autonomous driving, and effectively escort the safe development of emerging future industries.Suzhou International Development Group increased its capital to 22 billion yuan, with an increase of 120%. According to Tianyancha App, Suzhou International Development Group Co., Ltd. has undergone industrial and commercial changes recently, and its registered capital has increased from 10 billion yuan to 22 billion yuan, with an increase of 120%. Suzhou International Development Group Co., Ltd. was established in August 1995, and its legal representative is Zhang Tao. Its business scope covers the operation and management of state-owned assets within the scope of authorization, domestic commerce and material supply and marketing, and provides various consulting services, and it is wholly owned by Suzhou Municipal Finance Bureau.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
Guangxi: In November, 23,774 cases of legal infectious diseases were reported and 320 people died. The Health and Health Commission of Guangxi Zhuang Autonomous Region announced the epidemic situation of legal infectious diseases in Guangxi in November 2024. No cases of Class A infectious diseases were reported. 14,775 cases of Class B infectious diseases were reported, with 320 deaths. The reported diseases include AIDS, viral hepatitis, rabies, dengue fever, dysentery, tuberculosis, typhoid plus paratyphoid, whooping cough, scarlet fever, brucellosis, gonorrhea, syphilis, leptospirosis, malaria, novel coronavirus infection and monkeypox. The top five reported cases were viral hepatitis, tuberculosis, syphilis, AIDS and gonorrhea, accounting for 94.34% in total. 8999 cases of Class C infectious diseases were reported, with no death. The reported diseases include influenza, mumps, rubella, acute hemorrhagic conjunctivitis, leprosy, typhus, other infectious diarrhea and hand, foot and mouth disease. The top three reported cases were other infectious diarrhea, hand-foot-mouth disease and influenza, accounting for 91.43% in total.Treasury futures turned green for 30 years, and treasury futures turned down. The 30-year main contracts turned green and fell by 0.03% to 116.94. The 10-year main contract was reported at 108.17, and the increase narrowed to 0.02%.The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.
Strategy guide
Strategy guide 12-13
Strategy guide 12-13